Ryanodine receptor type 1-related congenital myopathies (RYR1-RCM) are the most represented subgroup among congenital myopathies (CM) and are associated with mutations in RYR1 (1–3). This evidence concerns the gene RYR1 and cutaneous mastocytosis.